SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Bruce Rosen who wrote (1381)12/29/1997 12:02:00 AM
From: Bill Wexler  Read Replies (1) | Respond to of 7041
 
Bruce - would you happen to be familiar with the U.S. clinical trial known to the company as Zon-301?

Want to talk about the fact that the parallel study was unblinded with an 80mg test dose being given to each study participant?

Want to discuss the fact that before the participants were randomized in the study they knew what it was like to have a double dose?

Want to discuss the fact that one of the AEs (adverse events) was a heart attack?

Want to talk about the fact that Pfizer spent over $400 million on Viagra and that Schering's $10 million bet is a drop in the bucket...not to mention that Schering has a failed history of making winners out of orphan drugs.

Want to speculate about what Joe Podolski's victims are going to do after this stock falls to the gutter?

Want to speculate about the possibility that certain people associated with the company and with Raymond James may be so appalled with this fraud that they have chosen to tell the public what's really going on?